SEX HORMONE BINDING GLOBULIN (SHBG)

SEX HORMONE BINDING GLOBULIN (SHBG) is a specialized diagnostic biochemical test designed to measure the levels of SHBG in the blood. SHBG is a protein produced by the liver that binds to sex hormones, including testosterone, dihydrotestosterone, and estradiol, transporting them in the blood and regulating their bioavailability. Measuring SHBG is essential for accurately interpreting total hormone levels and assessing conditions related to hyperandrogenism, hypogonadism, and metabolic health.

Measurement of SHBG provides direct clinical insight into the active, free fraction of sex hormones. Because early identification of hormonal imbalances supports timely dietary, lifestyle, and medical intervention, specialized biochemical testing supplies essential clinical data for endocrinology, gynecology, internal medicine, and reproductive health evaluations.

The test requires a blood specimen collected by a qualified person using standard containers, followed by precise analysis using automated laboratory immunoassay techniques. Results must always be interpreted in conjunction with the patient's clinical presentation, total testosterone levels, and comprehensive hormone panels.

Benefits of SEX HORMONE BINDING GLOBULIN (SHBG) Testing

• Provides a critical measure of hormone binding and bioavailability.
• Helps evaluate hyperandrogenism, polycystic ovary syndrome (PCOS), and hypogonadism.
• Assists clinicians in endocrinology and gynecological evaluations.
• Aids in assessing insulin resistance and metabolic status.
• Supports tracking of specialized hormonal and metabolic care plans.
• Complements total testosterone, free testosterone, and estrogen hormone panels.
• Utilizes precise laboratory immunoassay techniques for reliable results.
• Assists specialists in determining appropriate medical and hormonal management strategies.
• Provides dependable turnaround times to support specialized clinical care.
• Utilizes standard venous blood collection procedures.

Clinical Indications and Applications

Hormone Screening: The primary clinical indication is evaluating patients presenting with symptoms of hyperandrogenism, infertility, menstrual irregularities, or unexplained hormonal abnormalities.

Clinical Assessment: The test is utilized when screening for bioavailable testosterone issues in specialized clinical settings.

Why Doctors Recommend This Test

Endocrinologists, gynecologists, internal medicine specialists, and physicians recommend this test when investigating hormonal irregularities or managing reproductive health. It delivers essential quantitative data required to guide safe clinical intervention.

Following proper blood collection guidelines will ensure a smooth and efficient testing procedure.

What Happens During The Procedure?

The collection procedure involves obtaining a blood specimen drawn from a vein by a qualified phlebotomist using a clean, standard collection container provided by the healthcare facility under appropriate supervision protocols.

Once obtained, the sample is tested in the laboratory using advanced immunoassay analyzers to quantify SHBG concentrations. The procedure takes only a few minutes.

Normal Reporting Time

The report for the SEX HORMONE BINDING GLOBULIN (SHBG) test is generally available within 24 to 48 hours due to standard laboratory processing times. Results must be reviewed promptly with the referring physician or specialist.

Who Should Consider This Test?

• Women evaluated for polycystic ovary syndrome (PCOS), infertility, or signs of high androgens.
• Individuals investigated for hormonal imbalances or androgen status as directed by a clinician.

Understanding Test Results

Test results provide quantitative concentrations of SHBG, evaluated against established laboratory reference ranges for gender and age.

Elevated Findings: High SHBG levels can reduce the free, active hormone fraction, potentially indicating certain metabolic or liver-related conditions.

Low Findings: Low SHBG levels are often associated with insulin resistance, obesity, and hyperandrogenism, such as in PCOS.

Clinical Limitations

SHBG levels must be interpreted alongside total and free hormone concentrations and the patient's full clinical profile.

Important Safety Information

Severe hormonal symptoms or acute medical conditions require immediate medical attention. Patients must consult their healthcare provider or specialist to interpret endocrine screening findings.